Auris Medical Posts Wider Loss In Q1 - Quick Facts

(RTTNews) - Auris Medical Holding AG (EARS) reported a first-quarter net loss of 8.9 million Swiss francs, or 0.26 francs per share, compared to a loss of 8.05 million francs, or 0.28 francs per share, for the first quarter of 2015. The company noted that its net loss includes a net unrealized foreign currency exchange loss of 1.54 million francs in the first quarter of 2016 compared to a loss of 0.89 million francs in the first quarter of 2015.

Research and development expenses for the first quarter of 2016 were 6.1 million francs compared to 6.2 million francs, a year ago.

"We are focused on the continued progress of our two Phase 3 development programs evaluating AM-101 for acute inner ear tinnitus and AM-111 for acute inner ear hearing loss," said Thomas Meyer, Auris Medical's founder, Chairman and CEO.